HBV-IN-16

HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA) . cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1) [1].

Product Specifications

CAS Number

[2355225-38-4]

UNSPSC

12352005

Target

DNA/RNA Synthesis; HBV

Type

Reference compound

Related Pathways

Anti-infection; Cell Cycle/DNA Damage

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/hbv-in-16.html

Solubility

10 mM in DMSO

Smiles

ClC1=CC=CC2=C1N=C(C3=CC=C(C=C3)OCCO[C@H]4C[C@H](C4)C(O)=O)C=C2

Molecular Formula

C22H20ClNO4

Molecular Weight

397.85

References & Citations

[1] Song Feng, et al. Novel quinoline compounds for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2019121357A1.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MAB12073AF532 0.1 mL

Mouse Monoclonal IL-17RB Antibody (938923) [Alexa Fluor 532]

Ask

View Details

APR33144G-01 50 µL

AKAP8 Antibody (Center) [APR33144G]

Ask

View Details

APR33144G-02 100 µL

AKAP8 Antibody (Center) [APR33144G]

Ask

View Details

APR33144G-03 200 µL

AKAP8 Antibody (Center) [APR33144G]

Ask

View Details

APR33144G-04 400 µL

AKAP8 Antibody (Center) [APR33144G]

Ask

View Details

RR213770L4 10 µg

Cyp11b1 (NM_012537) Rat Tagged Lenti ORF Clone

Ask

View Details